Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation ECCO Congress Further Highlights Commitment to the GI Community

New biomarker data from the openlabel extension OLE of the Phase 2 OASIS trial for etrasimod in patients with moderately to severely active ulcerative colitis UC Arena sponsored dinner sy...